We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antibacterial Soap May Disrupt Intestinal Microbiota in Fetuses

By HospiMedica International staff writers
Posted on 10 Apr 2016
A new study reveals that using nonprescription soaps containing the antimicrobial triclocarban (TCC) during pregnancy and breast-feeding may alter the composition of intestinal bacteria in offspring.

Researchers at the University of Tennessee (Knoxville, USA) conducted a study that involved feeding female rats chow supplemented with TCC throughout pregnancy, and during a 16-day nursing period after the rat pups were born. More...
They collected fecal samples from the maternal rats during pregnancy and nursing, and also collected the contents of the cecum—an area connecting the small and large intestines—from the nursing pups to test the gut microbiota.

The researchers then performed DNA sequencing of the collected samples, and compared them with gut microbiota analysis of rats and their pups that were not exposed to TCC. The results showed that TCC led to a reduced average number of the microbial taxa present among mother rats and their pups; in addition, by postnatal day 16, the nursing pups exposed to TCC had a significantly different composition of gut microbiota from that of unexposed pups. The study was presented at the Endocrine Society's 98th annual meeting, held during April 2016 in Boston (MA, USA).

“Many antibacterial personal care products are commonly used during pregnancy and by nursing women to protect against infectious disease,” said lead author graduate student Rebekah Kennedy, MSc. “The ability of TCC antimicrobial exposure to change the composition of the microbial community warrants future investigation to determine the health outcomes … during sensitive windows of prenatal development and early life.”

Over 2,200 anti-bacterial hand soaps and body washes are currently available for consumers in the United States, but there is no scientific evidence showing these products are any more effective at preventing illness than washing hands with plain soap and water. In fact, some data suggest that long-term exposure to certain active ingredients used in anti-bacterial products, such as triclosan and TCC, could pose health risks such as bacterial resistance or interference with hormones such as estrogen, testosterone, and thyroid hormones.

Related Links:

University of Tennessee



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.